Symbicort Inhaler 320mcg/9mcg

What is Symbicort Inhaler 320mcg/9mcg?

Symbicort Inhaler 320mcg/9mcg is a prescription combination medication containing budesonide (320 mcg), an inhaled corticosteroid (ICS), and formoterol fumarate dihydrate (9 mcg), a long-acting beta2-adrenergic agonist (LABA). AstraZeneca manufactures this medication and delivers it through a metered-dose inhaler (MDI). Doctors primarily use it to manage asthma in patients aged 12 years and older. Budesonide reduces airway inflammation, while formoterol relaxes the airway muscles to improve breathing. Regulatory authorities in some regions, such as the U.S., have not approved it for treating chronic obstructive pulmonary disease (COPD). Additionally, doctors do not prescribe it as a rescue inhaler for sudden or acute symptoms.

Benefits

• Enhanced Lung Function: Reduces airway inflammation and eases breathing within 5–15 minutes, with sustained improvements after 1–2 weeks of regular use.

• Symptom Prevention: Controls persistent asthma symptoms (wheezing, shortness of breath), reducing exacerbations and reliance on rescue inhalers.

• Dual Action: Combines anti-inflammatory (budesonide) and bronchodilator (formoterol) effects for comprehensive asthma control.

• Convenient Use: Suitable for patients with severe asthma requiring higher corticosteroid doses; may be used off-label as Single Maintenance and Reliever Therapy (SMART) for asthma in some cases.

Uses

• Asthma Management: Prevents and controls asthma symptoms in patients 12 years and older with moderate to severe asthma not adequately controlled by low- or medium-dose ICS or requiring both ICS and LABA.

• Pre-Exercise Asthma Prevention: When taken before exposure to triggers (e.g., exercise, allergens), it helps prevent asthma attacks.

• Off-Label Use: May be prescribed for other respiratory conditions as determined by a healthcare provider, though not typically used for for COPD in regions like the U.S.

• Maintenance Therapy: Provides long-term daily control of asthma symptoms to reduce the frequency of flare-ups.

Side Effects

• Common: Throat irritation, hoarseness, oral candidiasis (thrush), headache, nasopharyngitis, upper respiratory tract infection, sinusitis, or mild tremors. Rinsing the mouth after use reduces thrush risk.

• Serious (Rare): Paradoxical bronchospasm, severe allergic reactions (rash, hives, swelling, breathing difficulty), adrenal suppression, cardiovascular effects (e.g., increased heart rate, palpitations), glaucoma, cataracts, or decreased bone density. Seek immediate medical attention if these occur.

• Other: Nervousness, hypokalemia, hyperglycemia, or potential growth retardation in adolescents. Regular monitoring (e.g., eye exams, bone health) is advised.

• Precautions: Contraindicated in patients with hypersensitivity to budesonide or formoterol, or for acute asthma attacks. Use cautiously in patients with cardiovascular disorders, diabetes, thyroid issues, or pregnancy (consult a doctor). Avoid in untreated infections, tuberculosis, or ocular herpes simplex. Do not combine with other LABAs or abruptly stop systemic corticosteroids. Inform your doctor of all medications to avoid interactions (e.g., ketoconazole, beta-blockers, MAOIs).